This content is machine translated 11th Swiss IBD Roadshow “Curing mucosa is our major goal” The meanwhile 11th Swiss IBD Roadshow (10. – 12. June 2024) took place this year under the title “ADVANCED THERAPIES IN IBD – TOWARDS A NEW SEQUENCE”. Between his lectures…
View Post 7 min This content is machine translated Interview with Prof. Thomas Kündig (USZ) and Prof. Diego Kyburz (USB) “You have to stop treating psoriasis as just a skin disease”. In Switzerland, psoriasis affects about 1 to 3 percent of the population [1]. About one in three psoriasis patients also suffers from psoriatic arthritis (PsA), a chronic inflammatory systemic disease that…
View Post 5 min This content is machine translated Obesity GLP-1-based drugs close the treatment gap The WHO has declared obesity to be a global health problem and weight reduction is an important measure in the prevention and treatment of metabolic diseases such as type 2…
View Post 8 min This content is machine translated Atopic dermatitis Reaching the goal with stage-adapted treatment and patient education The updated German-language guideline for the treatment of atopic dermatitis (AD) is based on the EuroGuiDerm guideline and has been expanded to include some important new features. Since AD is…
View Post 5 min This content is machine translated Sponsored Content: Atopic dermatitis: Roadshow 2024 Better standard of care through joint decision-making The first Swiss Atopic Dermatitis (AD) Roadshow took place at the beginning of February 2024. AD expert Prof. Jonathan Silverberg from the George Washington University School of Medicine and Health…
View Post 5 min This content is machine translated Endometrial Cancer Dostarlimab in everyday clinical practice: initial experiences with diagnostics and therapy Patients with primary advanced or recurrent endometrial cancer have a poor prognosis, particularly in the long-term course of treatment with carboplatin plus paclitaxel. This can be significantly improved with the…
View Post 4 min This content is machine translated Light skin cancer Prevention and early detection of an underestimated disease Light skin cancers are the most common cancers in fair-skinned people. They occur in at least 200 out of 100,000 people per year in Germany, especially basal cell carcinoma and…
View Post 5 min This content is machine translated Atopic dermatitis in the era of precision medicine Research into molecular biomarkers opens up new horizons The identification and study of molecular biomarkers may help to dissect the complex phenotype of atopic dermatitis into subphenotypes. A long-term goal of this translational research is the stratification and…
View Post 1 min This content is machine translated Podcast JAK inhibitors in inflammatory rheumatic diseases. Thanks to the development of advanced therapies, the goal of remission is within reach for more and more patients with inflammatory rheumatic diseases [1]. In the following podcast, Prof. Stephan…
View Post 5 min This content is machine translated Atopic dermatitis: system therapy Patient-centered care as the key to successful treatment The therapeutic landscape in the field of atopic dermatitis is changing. The spectrum of biologics and JAK inhibitors has expanded. Study data attest to the high efficacy of all currently…
View Post 3 min This content is machine translated Video interview with two professionals Individualized therapy decisions in osteoporosis The chronic metabolic disease osteoporosis is particularly prevalent among postmenopausal women and can lead to severe health complications [1]. Judith Everts-Graber, MD, and Prof. Serge Ferrari discuss in a video interview…
